Literature DB >> 12958476

DNA extraction from tissue.

Helen Pearson1, David Stirling.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12958476     DOI： 10.1385/1-59259-384-4:33

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN： 1064-3745


× No keyword cloud information.
  11 in total

1.  Molecular subtyping of primary prostate cancer reveals specific and shared target genes of different ETS rearrangements.

Authors:  Paula Paulo; Franclim R Ribeiro; Joana Santos; Diana Mesquita; Mafalda Almeida; João D Barros-Silva; Harri Itkonen; Rui Henrique; Carmen Jerónimo; Anita Sveen; Ian G Mills; Rolf I Skotheim; Ragnhild A Lothe; Manuel R Teixeira
Journal:  Neoplasia       Date:  2012-07       Impact factor: 5.715

2.  Anatomic Neuroimaging Characteristics of Posterior Fossa Type A Ependymoma Subgroups.

Authors:  N D Sabin; S N Hwang; P Klimo; N Chambwe; R G Tatevossian; T Patni; Y Li; F A Boop; E Anderson; A Gajjar; T E Merchant; D W Ellison
Journal:  AJNR Am J Neuroradiol       Date:  2021-10-21       Impact factor: 3.825

3.  Promoter methylation and large intragenic rearrangements of DPYD are not implicated in severe toxicity to 5-fluorouracil-based chemotherapy in gastrointestinal cancer patients.

Authors:  Joana Savva-Bordalo; João Ramalho-Carvalho; Manuela Pinheiro; Vera L Costa; Angelo Rodrigues; Paula C Dias; Isabel Veiga; Manuela Machado; Manuel R Teixeira; Rui Henrique; Carmen Jerónimo
Journal:  BMC Cancer       Date:  2010-09-01       Impact factor: 4.430

4.  Enoxacin inhibits growth of prostate cancer cells and effectively restores microRNA processing.

Authors:  Elsa Sousa; Inês Graça; Tiago Baptista; Filipa Q Vieira; Carlos Palmeira; Rui Henrique; Carmen Jerónimo
Journal:  Epigenetics       Date:  2013-04-17       Impact factor: 4.528

5.  High resolution melting analysis of KRAS, BRAF and PIK3CA in KRAS exon 2 wild-type metastatic colorectal cancer.

Authors:  Joana G Guedes; Isabel Veiga; Patrícia Rocha; Pedro Pinto; Carla Pinto; Manuela Pinheiro; Ana Peixoto; Maria Fragoso; Ana Raimundo; Paula Ferreira; Manuela Machado; Nuno Sousa; Paula Lopes; António Araújo; Joana Macedo; Fernando Alves; Camila Coutinho; Rui Henrique; Lúcio L Santos; Manuel R Teixeira
Journal:  BMC Cancer       Date:  2013-04-01       Impact factor: 4.430

6.  MicroRNA promoter methylation: a new tool for accurate detection of urothelial carcinoma.

Authors:  Nuno André Padrão; Sara Monteiro-Reis; Jorge Torres-Ferreira; Luís Antunes; Luís Leça; Diana Montezuma; João Ramalho-Carvalho; Paula C Dias; Paula Monteiro; Jorge Oliveira; Rui Henrique; Carmen Jerónimo
Journal:  Br J Cancer       Date:  2017-01-12       Impact factor: 7.640

7.  A DNA Methylation-Based Test for Breast Cancer Detection in Circulating Cell-Free DNA.

Authors:  Sofia Salta; Sandra P Nunes; Mário Fontes-Sousa; Paula Lopes; Micaela Freitas; Margarida Caldas; Luís Antunes; Fernando Castro; Pedro Antunes; Susana Palma de Sousa; Rui Henrique; Carmen Jerónimo
Journal:  J Clin Med       Date:  2018-11-07       Impact factor: 4.241

8.  Potential downstream target genes of aberrant ETS transcription factors are differentially affected in Ewing's sarcoma and prostate carcinoma.

Authors:  Maria J Camões; Paula Paulo; Franclim R Ribeiro; João D Barros-Silva; Mafalda Almeida; Vera L Costa; Nuno Cerveira; Rolf I Skotheim; Ragnhild A Lothe; Rui Henrique; Carmen Jerónimo; Manuel R Teixeira
Journal:  PLoS One       Date:  2012-11-19       Impact factor: 3.240

9.  Quantitative promoter methylation analysis of multiple cancer-related genes in renal cell tumors.

Authors:  Vera L Costa; Rui Henrique; Franclim R Ribeiro; Mafalda Pinto; Jorge Oliveira; Francisco Lobo; Manuel R Teixeira; Carmen Jerónimo
Journal:  BMC Cancer       Date:  2007-07-23       Impact factor: 4.430

10.  Deregulation of PAX2 expression in renal cell tumours: mechanisms and potential use in differential diagnosis.

Authors:  Patrícia Patrício; João Ramalho-Carvalho; Pedro Costa-Pinheiro; Mafalda Almeida; João Diogo Barros-Silva; Joana Vieira; Paula Cristina Dias; Francisco Lobo; Jorge Oliveira; Manuel R Teixeira; Rui Henrique; Carmen Jeronimo
Journal:  J Cell Mol Med       Date:  2013-07-26       Impact factor: 5.310
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.